查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128661

全球腦室外引流市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global External Ventricular Drain Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 209 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球腦室外引流市場預計將從2025年的21.8億美元成長至2034年的49.3億美元，2026年至2034年的複合年成長率（CAGR）為9.49%。該市場正經歷穩定成長，主要原因是全球神經系統疾病、創傷性腦損傷、水腦症和顱內出血的盛行率不斷上升。腦室外引流廣泛應用於重症監護環境中，用於控制腦脊髓液引流，同時監測和管理顱內壓。由於人們越來越意識到早期療育神經系統急症的重要性，醫院正在加強其神經重症監護能力。此外，導管設計、引流系統、感染控制能力和壓力監測技術的改進也推動了產品的應用。對先進重症監護基礎設施投資的增加也為市場擴張創造了機會。

推動神經外科手術需求成長要素之一是中風、頭部外傷、腦腫瘤及其他顱內壓增高疾病導致的神經外科手術患者數量不斷增加。醫院日益重視持續的神經系統監測和及時的腦脊髓液管理，這推動了對腦室外引流系統的需求。旨在減少導管相關感染的技術進步也進一步促進了該系統的應用。隨著這些系統在新興醫療市場（尤其是專業神經重症加護病房不斷湧現的地區）的普及，預計三級醫療機構和急診的使用範圍將進一步擴大。

隨著醫療專業人員日益重視病患監測、感染預防和微創神經外科手術，市場前景依然光明。預計製造商將致力於開發更安全的引流系統，改善壓力控制機制，增強監測功能，並提高易用性。亞太地區、拉丁美洲和中東醫院基礎設施的擴建有望創造更多機會。此外，醫療設備製造商與醫療機構之間更深入的合作有望加速產品創新。由於神經系統急症仍需快速有效的干預措施，未來幾年對可靠的腦室引流解決方案的需求預計將保持強勁。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含多個關鍵組成部分，旨在幫助您全面了解市場環境。

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：本部分詳細評估了主要市場參與企業，包括其市場定位、產品系列、策略舉措和財務表現。它提供了有關競爭對手趨勢和主要參與者所採取的策略的寶貴見解。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新的投資機會。本部分重點在於潛在的成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足客戶的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更好地支援策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球腦室外引流市場：依應用領域分類

  • 市場分析、洞察與預測
  • 創傷性腦損傷
  • 蜘蛛網膜下腔出血
  • 腦出血
  • 其他非創傷性水腦症疾病

第5章 全球腦室外引流市場：依病患類型分類

  • 市場分析、洞察與預測
  • 成人
  • 兒童

第6章 全球腦室外引流市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 其他

第7章 全球腦室外引流市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和分銷通路合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Spiegelberg GmbH & Co. KG
    • Medtronic
    • Sophysa
    • Natus Medical Incorporated
    • Neuromedex GmbH
    • Integra LifeSciences
    • Moller Medical GmbH
    • B. Braun SE
    • Fuji Systems
    • Johnson & Johnson MedTech
    • Raumedic AG
    • Wellong Instruments Co.Ltd
    • Dispomedica GmbH
    • Delta Surgical Limited
    • Ventura Medical Technologies
    • Ad-Tech Medical Instrument Corporation
    • Neurovent AG
    • Orsan Medical Technologies
    • Medprin BIoTech GmbH
    • G. Surgiwear Ltd
    • HLL Lifecare Limited
    • Cook Medical
    • Vygon SA
    • Teleflex Incorporated
    • BD
    • Smiths Medical
    • ICU Medical Inc
    • Nipro Corporation
簡介目錄
Product Code: VMR112119419

The global external ventricular drain market size is expected to reach USD 4.93 Billion in 2034 from USD 2.18 Billion in 2025, growing at a CAGR of 9.49% during 2026-2034.This market is witnessing steady growth as the prevalence of neurological disorders, traumatic brain injuries, hydrocephalus, and intracranial hemorrhage increases globally. External ventricular drains are widely used to monitor and manage intracranial pressure while providing controlled cerebrospinal fluid drainage in critical-care settings. Growing awareness regarding early intervention for neurological emergencies is encouraging hospitals to strengthen neurocritical-care capabilities. In addition, improvements in catheter design, drainage systems, infection-control features, and pressure-monitoring technologies are supporting product adoption. Increasing investments in advanced intensive-care infrastructure are also creating favorable opportunities for market expansion.

A major growth driver is the rising number of patients requiring neurosurgical intervention following strokes, head trauma, brain tumors, and other conditions associated with elevated intracranial pressure. Hospitals are increasingly emphasizing continuous neurological monitoring and timely cerebrospinal fluid management, which supports demand for external ventricular drainage systems. Technological developments aimed at reducing catheter-related infections are further strengthening adoption. The growing availability of specialized neurocritical-care units, particularly in emerging healthcare markets, is expected to improve access to these systems and broaden their utilization across tertiary and emergency-care facilities.

Future prospects remain positive as healthcare providers increasingly prioritize patient monitoring, infection prevention, and minimally invasive neurological procedures. Manufacturers are expected to focus on developing safer drainage systems with improved pressure-control mechanisms, enhanced monitoring capabilities, and easier handling. Expansion of hospital infrastructure in Asia Pacific, Latin America, and the Middle East is likely to create additional opportunities. Furthermore, increasing collaboration between medical device companies and healthcare institutions could accelerate product innovation. As neurological emergencies continue to require rapid and controlled intervention, demand for reliable ventricular drainage solutions is expected to remain strong over the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Application

  • Traumatic Brain Injury
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage
  • Other Non-Traumatic Hydrocephalus Conditions

By Patient Type

  • Adult
  • Pediatric

By End User

  • Hospitals
  • Others

COMPANIES PROFILED

  • Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Natus Medical Incorporated, Neuromedex GmbH, Integra LifeSciences, Moller Medical GmbH, B. Braun SE, Fuji Systems, Johnson & Johnson MedTech, Raumedic AG, Wellong Instruments Co.Ltd., Dispomedica GmbH, Delta Surgical Limited, Ventura Medical Technologies, Ad-Tech Medical Instrument Corporation, Neurovent AG, Orsan Medical Technologies, Medprin Biotech GmbH, G. Surgiwear Ltd., HLL Lifecare Limited, Cook Medical, Vygon SA, Teleflex Incorporated, BD, Smiths Medical, ICU Medical Inc., Nipro Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Traumatic Brain Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Subarachnoid Hemorrhage Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Intracerebral Hemorrhage Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Other Non-Traumatic Hydrocephalus Conditions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY PATIENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Patient Type
  • 5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Application
    • 7.2.2 By Patient Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Application
    • 7.3.2 By Patient Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Application
    • 7.4.2 By Patient Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Application
    • 7.5.2 By Patient Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Application
    • 7.6.2 By Patient Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EXTERNAL VENTRICULAR DRAIN INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Spiegelberg GmbH & Co. KG
    • 9.2.2 Medtronic
    • 9.2.3 Sophysa
    • 9.2.4 Natus Medical Incorporated
    • 9.2.5 Neuromedex GmbH
    • 9.2.6 Integra LifeSciences
    • 9.2.7 Moller Medical GmbH
    • 9.2.8 B. Braun SE
    • 9.2.9 Fuji Systems
    • 9.2.10 Johnson & Johnson MedTech
    • 9.2.11 Raumedic AG
    • 9.2.12 Wellong Instruments Co.Ltd
    • 9.2.13 Dispomedica GmbH
    • 9.2.14 Delta Surgical Limited
    • 9.2.15 Ventura Medical Technologies
    • 9.2.16 Ad-Tech Medical Instrument Corporation
    • 9.2.17 Neurovent AG
    • 9.2.18 Orsan Medical Technologies
    • 9.2.19 Medprin Biotech GmbH
    • 9.2.20 G. Surgiwear Ltd
    • 9.2.21 HLL Lifecare Limited
    • 9.2.22 Cook Medical
    • 9.2.23 Vygon SA
    • 9.2.24 Teleflex Incorporated
    • 9.2.25 BD
    • 9.2.26 Smiths Medical
    • 9.2.27 ICU Medical Inc
    • 9.2.28 Nipro Corporation